Protein expression based multimarker analysis of breast cancer samples
<p>Abstract</p> <p>Background</p> <p>Tissue microarray (TMA) data are commonly used to validate the prognostic accuracy of tumor markers. For example, breast cancer TMA data have led to the identification of several promising prognostic markers of survival time. Several...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-06-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/11/230 |
id |
doaj-b1a3702b0b484de6bb4414baab29aba0 |
---|---|
record_format |
Article |
spelling |
doaj-b1a3702b0b484de6bb4414baab29aba02020-11-24T22:01:01ZengBMCBMC Cancer1471-24072011-06-0111123010.1186/1471-2407-11-230Protein expression based multimarker analysis of breast cancer samplesRajasekaran Ayyappan KMaresh Erin LAlavi MohammadMah VeiBagryanova LoraYoon Nam KPresson Angela PGoodglick LeeChia DavidHorvath Steve<p>Abstract</p> <p>Background</p> <p>Tissue microarray (TMA) data are commonly used to validate the prognostic accuracy of tumor markers. For example, breast cancer TMA data have led to the identification of several promising prognostic markers of survival time. Several studies have shown that TMA data can also be used to cluster patients into clinically distinct groups. Here we use breast cancer TMA data to cluster patients into distinct prognostic groups.</p> <p>Methods</p> <p>We apply weighted correlation network analysis (WGCNA) to TMA data consisting of 26 putative tumor biomarkers measured on 82 breast cancer patients. Based on this analysis we identify three groups of patients with low (5.4%), moderate (22%) and high (50%) mortality rates, respectively. We then develop a simple threshold rule using a subset of three markers (p53, Na-KATPase-β1, and TGF β receptor II) that can approximately define these mortality groups. We compare the results of this correlation network analysis with results from a standard Cox regression analysis.</p> <p>Results</p> <p>We find that the rule-based grouping variable (referred to as WGCNA*) is an independent predictor of survival time. While WGCNA* is based on protein measurements (TMA data), it validated in two independent Affymetrix microarray gene expression data (which measure mRNA abundance). We find that the WGCNA patient groups differed by 35% from mortality groups defined by a more conventional stepwise Cox regression analysis approach.</p> <p>Conclusions</p> <p>We show that correlation network methods, which are primarily used to analyze the relationships between gene products, are also useful for analyzing the relationships between patients and for defining distinct patient groups based on TMA data. We identify a rule based on three tumor markers for predicting breast cancer survival outcomes.</p> http://www.biomedcentral.com/1471-2407/11/230Tissue microarraybreast cancertumor markerprognostic markerWGCNA |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Rajasekaran Ayyappan K Maresh Erin L Alavi Mohammad Mah Vei Bagryanova Lora Yoon Nam K Presson Angela P Goodglick Lee Chia David Horvath Steve |
spellingShingle |
Rajasekaran Ayyappan K Maresh Erin L Alavi Mohammad Mah Vei Bagryanova Lora Yoon Nam K Presson Angela P Goodglick Lee Chia David Horvath Steve Protein expression based multimarker analysis of breast cancer samples BMC Cancer Tissue microarray breast cancer tumor marker prognostic marker WGCNA |
author_facet |
Rajasekaran Ayyappan K Maresh Erin L Alavi Mohammad Mah Vei Bagryanova Lora Yoon Nam K Presson Angela P Goodglick Lee Chia David Horvath Steve |
author_sort |
Rajasekaran Ayyappan K |
title |
Protein expression based multimarker analysis of breast cancer samples |
title_short |
Protein expression based multimarker analysis of breast cancer samples |
title_full |
Protein expression based multimarker analysis of breast cancer samples |
title_fullStr |
Protein expression based multimarker analysis of breast cancer samples |
title_full_unstemmed |
Protein expression based multimarker analysis of breast cancer samples |
title_sort |
protein expression based multimarker analysis of breast cancer samples |
publisher |
BMC |
series |
BMC Cancer |
issn |
1471-2407 |
publishDate |
2011-06-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Tissue microarray (TMA) data are commonly used to validate the prognostic accuracy of tumor markers. For example, breast cancer TMA data have led to the identification of several promising prognostic markers of survival time. Several studies have shown that TMA data can also be used to cluster patients into clinically distinct groups. Here we use breast cancer TMA data to cluster patients into distinct prognostic groups.</p> <p>Methods</p> <p>We apply weighted correlation network analysis (WGCNA) to TMA data consisting of 26 putative tumor biomarkers measured on 82 breast cancer patients. Based on this analysis we identify three groups of patients with low (5.4%), moderate (22%) and high (50%) mortality rates, respectively. We then develop a simple threshold rule using a subset of three markers (p53, Na-KATPase-β1, and TGF β receptor II) that can approximately define these mortality groups. We compare the results of this correlation network analysis with results from a standard Cox regression analysis.</p> <p>Results</p> <p>We find that the rule-based grouping variable (referred to as WGCNA*) is an independent predictor of survival time. While WGCNA* is based on protein measurements (TMA data), it validated in two independent Affymetrix microarray gene expression data (which measure mRNA abundance). We find that the WGCNA patient groups differed by 35% from mortality groups defined by a more conventional stepwise Cox regression analysis approach.</p> <p>Conclusions</p> <p>We show that correlation network methods, which are primarily used to analyze the relationships between gene products, are also useful for analyzing the relationships between patients and for defining distinct patient groups based on TMA data. We identify a rule based on three tumor markers for predicting breast cancer survival outcomes.</p> |
topic |
Tissue microarray breast cancer tumor marker prognostic marker WGCNA |
url |
http://www.biomedcentral.com/1471-2407/11/230 |
work_keys_str_mv |
AT rajasekaranayyappank proteinexpressionbasedmultimarkeranalysisofbreastcancersamples AT maresherinl proteinexpressionbasedmultimarkeranalysisofbreastcancersamples AT alavimohammad proteinexpressionbasedmultimarkeranalysisofbreastcancersamples AT mahvei proteinexpressionbasedmultimarkeranalysisofbreastcancersamples AT bagryanovalora proteinexpressionbasedmultimarkeranalysisofbreastcancersamples AT yoonnamk proteinexpressionbasedmultimarkeranalysisofbreastcancersamples AT pressonangelap proteinexpressionbasedmultimarkeranalysisofbreastcancersamples AT goodglicklee proteinexpressionbasedmultimarkeranalysisofbreastcancersamples AT chiadavid proteinexpressionbasedmultimarkeranalysisofbreastcancersamples AT horvathsteve proteinexpressionbasedmultimarkeranalysisofbreastcancersamples |
_version_ |
1725842273704345600 |